Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia

Short summary

A study of 270 Nocardia isolates in Australia revealed Nocardia nova complex (29.6%) as the most common species, with 59.3% exhibiting resistance to imipenem and 9.3% to trimethoprim/sulfamethoxazole (SXT). Linezolid and amikacin showed high susceptibility across all tested isolates.

AI-generated from the title and abstract; the full text is not read.